Abrogated cell cycle control is a typical hallmark for most cancer cells, particularly for HNSCC, and several lines of evidence suggest a synthetic lethality between TP53 mutations and Chk1 inhibition in triple-negative breast cancer15–17. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.